CORT Financials

Corcept Therapeutics Incorporated - Financial statements & key metrics

Stock Price

$108.98

Market Cap

$7.46B

P/E Ratio

41.8

EPS

$0.87

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$675.04M

Gross Profit

Operating Income

Net Income

$141.21M

EPS (Diluted)

$1.23

Balance Sheet Highlights

Total Assets

$840.55M

Total Liabilities

$160.96M

Shareholders Equity

Cash & Equivalents

$127.67M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$198.07M

CapEx

Free Cash Flow

Profitability Metrics

Operating Margin

4.9%

Net Margin

14.3%

ROE

16.7%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is CORT revenue?

CORT's most recent quarterly revenue was $675.04M. Annual revenue can be calculated by summing the four most recent quarters.

Is CORT profitable?

CORT reported a profit of $141.21M in the most recent quarter. The net profit margin is 14.3%.

What is CORT market cap?

CORT has a market capitalization of $7.46B, making it a mid-cap stock.

Does CORT have debt?

View CORT's balance sheet for debt information.

What is CORT cash flow?

Cash flow data is available in the full financial statements.